MAAT INDEX

CLAIM #69802 · EMR (EMR) · 2026Q3 earnings call · Nov 2, 2026 · due Dec 31, 2027

China was down about 3% but is improving sequentially and we expect continued improvement into low-single-digit growth levels as we plan for 2027.

Lal Karsanbhai · CEO

PENDING
graded after results covering Dec 31, 2027 are reported

In context

Lal Karsanbhai (President and Chief Executive Officer): We've spoken about being bullish on the U.S. and the investments there; that has significant legs and we were up 10% in the U.S. in the quarter. I don't expect that to subside. Europe was down 1% in sales in the quarter but orders were positive in Europe, which is a good sign. China was down about 3% but is improving sequentially and we expect continued improvement into low-single-digit growth levels as we plan for 2027. Other Asia was very strong, powered by Japan, India and Southeast Asia.

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q3 earnings call.